Publications by authors named "Louise Ming"

Claim this Profile
T
Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression.
Heather Nesbitt, Niall M Byrne, S Nicole Williams, Louise Ming, Jenny Worthington

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response.
Louise Ming, Niall M Byrne, Sarah Nicole Camac, Christopher A Mitchell, Claire Ward

Int J Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype.
Karl T Butterworth, Helen O McCarthy, Andrea Devlin, Louise Ming, Tracy Robson

Int J Cancer· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis